The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Nusinersen for Adult Spinal Muscular Atrophy

Antisense oligonucleotide therapy targeting SMN2 splicing approved for spinal muscular atrophy across age groups, including adults with type 2, 3, and selected type 4 disease, administered intrathecally to increase functional SMN protein production and stabilize or improve motor function.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Nusinersen for Adult Spinal Muscular Atrophy?

Nusinersen is an antisense oligonucleotide that binds to a specific intronic splicing silencer site in the SMN2 pre-messenger RNA, promoting exon 7 inclusion and producing more full-length, functional SMN protein, addressing the underlying genetic cause of spinal muscular atrophy (SMA) caused by SMN1 deletion or mutation.

Approved for SMA across age groups, nusinersen has expanded eligibility for adults with SMA type 2 (juvenile-onset), type 3 (later-onset), and selected type 4 (adult-onset) patients with persistent motor disability, with administration as intrathecal injection (loading 4 doses then every 4 months maintenance).

Adult outcomes include stabilization or improvement of motor function (Hammersmith Functional Motor Scale Expanded, Revised Upper Limb Module, six-minute walk), respiratory function, fatigue, and quality of life, with evidence accumulating from long-term real-world cohorts that may differ from pediatric responses.

Symptoms

Progressive proximal muscle weakness with limb girdle, axial, and bulbar involvement
Respiratory insufficiency and reduced cough strength
Joint contractures, scoliosis, and skeletal complications
Dysphagia, weight loss, and nutritional concerns
Fatigue and reduced exercise tolerance
Functional impact on activities of daily living, mobility, and independence

Risk Factors

Confirmed SMA diagnosis with SMN1 biallelic deletion or pathogenic variant on genetic testing
SMN2 copy number influencing disease severity and response to therapy
Age, baseline motor function, and ambulatory status modifying treatment response
Severe scoliosis or spinal hardware complicating intrathecal access
Coexistent respiratory or cardiac comorbidities that may affect general anesthesia or sedation needed for intrathecal access in some patients
Adequate platelet count and coagulation parameters for safe lumbar puncture

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Adult patient with established SMA considering disease-modifying therapy — referral to specialized neuromuscular center for evaluation and individualized treatment planning
  • Newly diagnosed adult-onset SMA — multidisciplinary assessment with genetics, neurology, pulmonology, physiotherapy, and nutrition
  • Patient on nusinersen with worsening motor function or new symptoms — review of treatment adherence, alternative therapies (risdiplam, gene therapy considerations), and rehabilitation needs
  • Procedure-related concerns: severe scoliosis, prior spinal surgery, anticoagulation — interventional radiology or anesthesia consultation for safe intrathecal access
  • Pregnancy planning or pregnant patient with SMA — multidisciplinary care addressing therapy continuation, anesthesia, and obstetric risks

Treatment Methods

01
Comprehensive baseline assessment: motor function scales, respiratory testing, swallowing evaluation, nutrition, scoliosis imaging, and shared decision-making about therapy goals
02
Intrathecal nusinersen administration with loading regimen (4 doses over 2 months) and maintenance every 4 months in lifelong therapy
03
Image-guided lumbar puncture for patients with severe scoliosis or spinal hardware, including fluoroscopy or CT guidance
04
Multidisciplinary supportive care: physiotherapy, occupational therapy, respiratory care, orthotics, nutrition, mental health, and social support
05
Long-term outcome monitoring with standardized motor scales, respiratory tests, patient-reported outcomes, and evaluation of switching to or combining with risdiplam, gene therapy, or future emerging treatments

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Stroke

Nöroloji

What is stroke, what are the FAST signs, and why is emergency intervention critical?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.